Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Emerging Therapies Drive Analytical Advancements

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Analyzing Exabytes

Effective analytics will eliminate failures, deviations, and non-conformances.

A PAT Solution for Automated Mill Control

January 02, 2010

The authors describe the implementation of an on-line particle-size analyzer on an active pharmaceutical ingredient milling operation at a commercial site.

Refocusing Our Resources

January 02, 2010

From healthcare to corruption to life expectancy, here's what we can learn from the past decade.

Personnel Problems

January 02, 2010

Directors and staff miss the mark when it comes to following procedures.

Week of Dec. 28, 2009: Company and People Notes: Ambit Biosciences And Astellas Pharma Form Agreement; Merck Discontinues Development of MK-1903; and More.

December 31, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

BioNanomatrix (Philadelphia) names Edward Erickson president and CEO; and More.

Week of Dec. 21, 2009: Company and People Notes: Merck & Co.Acquires Avecia Biologics; Ambrilia Biopharma Closes Manufacturing Facility; And More.

December 23, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

Merck & Co. Acquires Avecia Biologics; Ambrilia Biopharma Closes Manufacturing Facility; And More.

Week of Dec. 14, 2009: Company Notes: Sanofi Pasteur recalls H1N1 vaccine; Patheon consolidates Puerto Rico operations.

December 17, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

Also, Abbott to acquire Starlims Technologies; GSK Biologicals to form alliance with Intercell.

Equipment and Processing Report

December 2009 Editor's Picks: Products from Sepha and AdvantaPure

December 16, 2009

PharmTech's monthly newsletter, Equipment & Processing Report, reviews the Editor's Picks for the December 2009 edition from Sepha and AdvantaPure.

Week of Dec. 7, 2009: Company and People Notes: PhRMA adds biopharm members; Dow spins off expression technology; and more.

December 10, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

Company and People Notes: Also, Pfizer and Protalix enter agreement; Watson acquires Arrow Group; and more.

Personalized Medicine Market to Grow by 11% Annually

December 10, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

Personalized medicine has been described by analysts PricewaterhouseCoopers as a "disruptive influence" that will create both opportunities and challenges for traditional healthcare.

Week of Nov. 30, 2009: Company and People Notes: BASF introduces new tablet-coating system; Catalent achieves ISO 15378 certification; and More.

December 03, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

Also, Merck & Co. extends collaboration with Idera Pharmaceuticals; Pfizer establishes R&D center in China; more...